3 suspended. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Suspended 3 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke Compound Edaravone Injection-Low dose, Compound Edaravone Injection-High dose, Edaravone Injection - Acute Ischemic Stroke | Phase 2 | Suspended | Nanjing Yoko Biomedical Co., Ltd. | 240 | 2021-11-15 | 2024-02-20 |
| A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes TF0023 - Ischemic Stroke | Phase 2 | Suspended | Techfields Inc | 225 | 2017-03-01 | 2024-01-05 |
| Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke Pinocembrin for Injection - Ischemic Stroke | Phase 2 | Suspended | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 216 | 2013-06-01 | 2016-06-20 |
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Stroke (3) · Vascular Diseases (3)
Bulk Drugs (1) · Edaravone (1) · Injections (1) · pinocembrin (1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Nanjing Yoko Biomedical Co., Ltd. (1) · Techfields Inc (1)
China (2) · United States (1)
Chongxi Yu, Ph.D (1) · Wang Yong Jun, Ph.D (1)